Evaluating a framework for tuberculosis screening among healthcare workers in clinical settings, Inner Mongolia, China
Journal of Occupational Medicine and Toxicology volume 13, Article number: 11 (2018)
Health care workers are at high risk for tuberculosis (TB). China, a high burden TB country, has no policy on medical surveillance for TB among healthcare workers. In this paper, we evaluate whether China’s national TB diagnostic guidelines could be used as a framework to screen healthcare workers for pulmonary TB disease in a clinical setting in China.
Between April–August 2010, healthcare workers from 28 facilities in Inner Mongolia Autonomous Region, China were eligible for TB screening, comprised of symptom check, chest X-ray and tuberculin skin testing. Healthcare workers were categorized as having presumptive, confirmed, or clinically-diagnosed pulmonary TB, using Chinese national guidelines.
All healthcare workers (N=4347) were eligible for TB screening, of which 4285 (99%) participated in at least one TB screening test. Of the healthcare workers screened, 2% had cough for ≥ 14 days, 3% had a chest X-ray consistent with TB, and 10% had a tuberculin skin test induration ≥ 20 mm. Of these, 124 healthcare workers were identified with presumptive TB (i.e., cough for ≥ 14 days in the past 4 weeks or x-ray consistent with TB). Twelve healthcare workers met the case definition for clinically-diagnosed pulmonary TB, but none were diagnosed with TB during the study period.
A substantial proportion of healthcare workers in Inner Mongolia had signs, symptoms, or test results suggestive of TB disease that could have been identified using national TB diagnostic guidelines as a screening framework. However, achieving medical surveillance in China will require a framework that increases the ease, accuracy, and acceptance of TB screening in the medical community. Routine screening with improved diagnostics should be considered to detect tuberculosis disease among healthcare workers and reduce transmission in health care settings in China.
Since 1990, China has experienced substantial declines in the burden of tuberculosis (TB) nationally , yet the country continues to have the third largest number of incident TB cases and the highest number of multidrug resistant (MDR) TB cases in the world . Healthcare workers (HCWs) are a high risk group for TB infection in China [3,4,5,6,7,8], possibly due to inadequate infection control practices in healthcare settings . However, medical surveillance of HCWs for TB disease is not routine, and there are no guidelines to screen HCWs for TB disease in China . As such, HCWs may develop TB disease, not be diagnosed in a timely manner and thus contribute to ongoing TB transmission. Accurate and timely diagnosis of TB disease is essential to ensure proper patient care and appropriate public health response.
Guidelines for routine TB screening among HCWs can help reduce ongoing transmission of TB and be used to monitor and evaluate existing nosocomial TB infection control policies . In lieu of these, China’s national TB diagnostic guidelines can serve as a framework for routine screening of HCWs for TB disease [10, 11], but the application of the diagnostic guidelines in this context has not been evaluated. To address this gap, we evaluated using China’s national TB diagnostic guidelines to screen HCWs for pulmonary TB disease in a clinical setting in Inner Mongolia. Inner Mongolia is an Autonomous Region in northern China, with a population of approximately 24 million people in the 2010 census. In 2010, the notification rate of active TB in China’s Inner Mongolia Autonomous Region was 74.1 per 100,000 and the notification rate for smear positive TB was 35.4 per 100,000 .
Facilities that diagnosed TB cases were selected based on their capability to conduct chest X-rays and their willingness to participate. All HCWs in the 28 selected healthcare facilities were eligible to participate. A HCW was defined as any person who received payment for working in the facility, regardless of the type of employment (e.g., clinicians, nurses, laboratorians, and administrative, janitorial, and cafeteria staff). The number of eligible HCWs at a facility ranged from 9 to 1000. HCWs undergoing TB treatment were excluded.
We used 2008 Chinese national diagnostic guidelines to define a TB case. Chinese national guidelines rely on clinical judgement based on symptoms, chest radiography, tuberculin skin test (TST), and smear microscopy to diagnose TB; the national guidelines do not include use of culture for TB diagnosis. Per these guidelines, a confirmed pulmonary TB case was defined as a person with sputum smear positive acid-fast bacilli (AFB) results; a clinically-diagnosed TB case was defined as a person with a chest X-ray consistent with TB and either a cough for more than 14 days in the past 4 weeks or a tuberculin skin test reading ≥20 mm [10, 11]. We defined a presumptive TB case as a person who, per Chinese national guidelines, was eligible for smear microscopy testing: i.e., one who had a chest X-ray consistent with TB or one who had cough for more than 14 days in the past 4 weeks.
Screening for TB
Between April and August 2010, HCWs were screened for active pulmonary TB disease following Chinese national guidelines, the first step of which included offering all HCWs a symptom screen, a chest x-ray, and TST. Project personnel administered a standardized questionnaire that included a TB symptom screen, such as cough for more than 14 days, and collected information on HCW demographics and risk factors for TB disease. A sub-set of participating health care workers were offered chest X-rays and TSTs; these HCWs were conveniently sampled by facility staff. Radiologists from each participating clinic independently reviewed chest X-rays for participating HCWs from their own facilities; no additional training was provided on taking and reading chest X-rays. Study staff were trained by China CDC to place TSTs and read and interpret the results, since TSTs were not routinely administered. Study staff performed a single-step TST using 5 IU (0.1 ml) of domestically-produced tuberculin derived from M. bovis BCG (Chengdu Institute of Biological Products, Chengdu, China).
Per national guidelines, facility staff were to refer an HCW for sputum smear microscopy if he/she had a chest X-ray suggestive of TB or symptoms of cough greater than 2 weeks, and were to follow routine facility procedures to record and report diagnosed cases. Presumptive TB cases should provide spot, morning and night sputum specimens. To identify TB cases, we searched the national electronic TB surveillance system for HCWs who were eligible for sputum smear evaluation (matching by name, age, gender and current address) to ascertain if they were diagnosed with active TB within 5 years of the project (from July 2010–July 2015).
All data were collected on paper forms and double-entered into Microsoft Excel (Redmond, WA, USA). Project staff conducted periodic site visits to monitor data quality and to provide ongoing training, as necessary. Frequencies and proportions were calculated and compared for all HCWs at each stage of the TB screening process. Data were analyzed using SAS 9.3 (SAS Institute, Cary, NC, USA).
HCWs provided written informed consent. The Chinese Ethical Committee for Tuberculosis Operational Research and the Chinese Center for Disease Control and Prevention approved this project.
Within the 28 facilities, 4347 HCWs were eligible to participate in the study. Of these, 3011 (69.3%) underwent symptom screening, 2311 (53%) received a chest x-ray, and 2568 (59%) received a TST (Fig. 1); 4285 HCWs participated in at least one of these screenings. There were no significant differences in the demographic characteristics between HCWs participating in each of the screening methods (data not shown). Among HCWs screened for symptoms, most were primarily medical doctors or nurses (47%), females (66%), never smokers (77%), and at least 40 years old (53%); half of participants had spent more than 15 years working in health care settings (52%) (Table 1). Most HCWs had never had a TST (80%) and, of the 591 HCWs who ever had a TST, 217 (37%) had a skin test within the last 5 years.
Among HCWs screened for symptoms, the majority of HCWs reported no TB symptoms (2714, 90%) (Table 1). Among HCWs receiving TST, 251 (10%) had a TST ≥20 mm. Among HCWs receiving chest X-rays, 125 (5%) had an abnormal result; this included 59 (47%) chest X-rays that were consistent with TB.
X-ray and symptom screening identified 124 HCWs with presumptive TB, who were thus eligible for sputum smear evaluation: 59 who had X-rays consistent with TB and 65 who reported cough for more than 14 days in the past 4 weeks (Fig. 1). There were no cases with both X-ray consistent with TB and cough for more than 14 days in the past 4 weeks. An unknown number of HCWs who should have been referred for sputum smear microscopy completed the test during the study period (i.e., April–August 2010) as facility staff only reported positive smear tests for HCWs and no smear results were reported. Between July 2010 and July 2015, however, 1 out of the 124 HCW eligible for sputum smear was reported in the national electronic TB surveillance system as having active TB disease.
Of the 2269 participants who completed both the symptom screening and a chest x-ray, 12 HCWs (0.53% or 529 per 100,000; 95% confidence interval [208, 849]) met the case definition for clinically-diagnosed, active pulmonary TB (i.e., X-ray consistent with TB and TST induration of at least 20 mm). However, despite meeting the case definition for active pulmonary TB disease, these 12 cases were not diagnosed with TB by their healthcare facilities. The majority of HCWs meeting the case definition for clinically-diagnosed TB were clinical staff (i.e., medical doctors or nurses) (7/12), had direct contact with TB patients (10/12) and had been working in healthcare settings for at least 6 years (9/12) (Table 1). Two-thirds of the HCWs who met the case definition for clinically diagnosed pulmonary TB were asymptomatic (i.e. reported no fever, night sweats, or cough in the last 4 weeks) (7/11) while nearly three quarters of HCWs with X-rays consistent with TB were asymptomatic (43/59).
TB is an under-recognized disease among healthcare workers in China. This study found that in Inner Mongolia, using China’s national TB diagnostic guidelines as a framework to screen HCWs for TB could have identified 12 HCWs with TB. Twelve HCWs met national guideline definitions for clinically diagnosed TB, which is equivalent to a prevalence of 529 (95% CI 208, 849) TB cases per 100,000, a number higher than the national TB prevalence (108 per 100,000)  and the provincial TB prevalence for Inner Mongolia (74 per 100,000) . However, during the study period, none of the HCWs meeting the criteria for clinically diagnosed TB were confirmed microbiologically, formally diagnosed with TB disease, or treated with anti-TB medications, and thus were not reported as TB cases. This suggests that while screening for TB among HCWs in China is urgently needed, using the national TB diagnostic algorithm as a framework for medical surveillance in itself may be insufficient. Effectiveness of screening programs may be hampered by lack of recognition of TB disease among HCWs, poor understanding or acceptance of diagnostic guidelines, and poor quality of tests used to diagnose TB, which would need to be addressed to achieve optimal medical TB surveillance in China.
Medical surveillance for occupationally-acquired diseases among HCWs is not routine in China  despite global recommendations to conduct on-site surveillance of TB among HCWs . We found 20 % of participating HCWs reported ever having a TST and fewer than half of those had the test within the last 5 years. If an HCW is diagnosed with TB in China, it is not generally acknowledged as an occupationally-acquired infection , even though our study found a high proportion of HCWs who met the case definition for sputum referral or for clinically-diagnosed TB had work related exposures (i.e., contact with TB patients or with coworkers with TB). The participation rate for the initial screening was high, with 98.5% participating in at least one screening method, indicating that there is capacity to conduct medical surveillance if prioritized by hospital management. Regular TB screening of HCWs would facilitate early identification of TB in this vulnerable population and reduce risk of TB transmission in healthcare settings.
This evaluation identified challenges in uptake of the current national TB diagnostic algorithm as a framework to screen HCWs for TB. Namely, the study found it difficult to achieve HCW participation in the full screening process, especially with smear microscopy. The low yield of smear positive TB cases identified in this study suggests that HCWs who should have been referred for sputum smear testing may not have completed testing. Previous studies in China have found that persons eligible for sputum smears are frequently not offered the test, and the number of individuals who complete a sputum exam among those offered a test is even lower [15, 16]. Most of the presumptive TB cases and participants who met the case definition of clinically-diagnosed pulmonary TB in this evaluation were asymptomatic which could have affected the perceived urgency for sputum testing. However, other barriers to being offered and completing sputum exams in China have been found to include economic constraints and innate beliefs held by both doctors and presumptive TB cases that sputum tests are unimportant [15, 16]. In addition, China does not have established protocols for referral and follow-up of asymptomatic HCWs with suspected TB. For routine TB screening to be effective among HCWs in China, additional research is needed to better understand the low uptake of sputum screening. Alternative laboratory-based screening methods that are more acceptable to HCWs may need to be considered, along with active follow up of presumptive TB cases to ensure they undergo appropriate laboratory-based TB testing.
The study also found that imperfections of the diagnostic tests used in the national TB diagnostic algorithm could hinder its use to conduct successful medical TB surveillance in HCWs. For example, identification of no smear positives in this study may have been partly due to challenges with the AFB sputum test as sensitivity for smear microscopy can range between 20 and 80% based on how samples are collected, stored, transported, and analyzed [17,18,19]. In contrast, radiography is non-specific for TB diagnosis, which makes diagnosis based on x-ray challenging [20,21,22,23]. Similarly, the utility of TST is also debatable, not only for active TB but for latent TB. The validity of TST results using Chinese domestically produced tuberculin have been questioned due to concerns about cross-reactivity with BCG vaccination [4, 7], which is provided to everyone at birth in China. Furthermore, healthcare facilities in China do not routinely perform TST on HCWs because of poor infrastructure for performing TST, high endemic rates of TB transmission, lack of policy on prophylaxis for TB infection, and limited recognition of the contribution of healthcare worker TB surveillance to TB control [7, 9]. A screening algorithm with more accurate testing methods could be needed to make routine medical surveillance for TB worthwhile in China.
The high number of HCWs who met the case definition for clinically-diagnosed pulmonary TB in this study but lacked microbiological testing suggests routine screening for active TB disease among healthcare workers in China could benefit by inclusion of more accurate and better accepted diagnostic tests, like WHO-approved rapid tests (e.g., Xpert® MTB/RIF [Xpert]). Due to their ease of use and rapid turn-around of results, these tests could be more appealing to healthcare workers; expanding use of these WHO-approved rapid tests could thus improve uptake of bacteriological testing. China’s Food and Drug Administration has approved use of Xpert for drug resistance testing among smear positive TB cases , but expanding the use of Xpert for TB diagnosis of smear negative TB cases has improved accuracy of TB diagnosis in other high-burden TB settings [25,26,27]. Although Xpert tests are expensive, modeling suggests that coupling same-day sputum microscopy with Xpert testing could reduce TB incidence and mortality in high-burden settings . Considering the high rate of MDR TB in China, incorporating drug resistance testing into routine medical surveillance for all HCWs would also be beneficial .
This evaluation has several limitations. This project was conducted in one autonomous region in China and may not be representative of China as a whole. We relied upon routine diagnostic practices and technologies used at the facility level, so we could not control for the quality of X-rays, sputum collection, or microscopy reading. As a result, quality may have varied substantially between the 28 facilities, which had a wide range of capacity for TB screening and referral. The lack of culture, or other confirmatory tests, within the screening algorithm also made it impossible to assess diagnostic accuracy. In addition, single-step TST tests were conducted which could have led to under-identification of TST positive participants due to the booster effect, thus under-diagnosing participants who met the case definition of clinically-diagnosed pulmonary TB. Conversely, the high prevalence of BCG vaccination in China and the local TST’s potential to cross-react with BCG vaccination could have resulted in an artificially high number of HCWs developing positive TSTs, thus overestimating number of participants who med the case definition of clinically-diagnosed pulmonary TB. Furthermore, as this study relied on the national TB policies and practices already in place for testing presumptive TB patients, facilities only reported on positive smear results, so the number of HCWs who completed AFB sputum testing was unknown; this could have led to underestimation of sputum smear positive TB cases. Similarly, we had to rely on the routine national electronic reporting system to know whether presumptive TB patients were diagnosed with TB after the study period because it was outside the scope of the study to follow HCWs after TB screening. Finally, no information was available on HCWs who chose not to participate in, or were not offered, TB screening, so intrinsic differences between participating and non-participating HCWs are unknown. Additional research is needed to elucidate reasons for HCW participation, or lack of participation, in the TB screening process.
Although the burden of TB in China has declined substantially since 1990, the country continues to bear a large portion of the world’s incident TB cases, with healthcare workers being at high risk for TB. China currently has no policy on medical surveillance for TB among HCWs. This study suggests that while using the current national TB diagnostic algorithm to screen HCWs for TB in China could be a start to actively find TB in this at-risk population, this framework would require adjustments to increase the ease, accuracy, and acceptance of TB screening in order to achieve optimal medical surveillance for TB in China. To do this, there is a need for stronger approaches to obtain microbiological evaluation on presumptive TB cases, which could include expanded use of Xpert or other WHO-approved rapid tests. Operational research would be necessary to fully elucidate the feasibility, costs, and benefits of adapting a revised TB screening algorithm for routine medical TB surveillance in China.
- China CDC:
China Center for Disease Control and Prevention
Tuberculin skin test
- US CDC:
United States Centers for Disease Control and Prevention
Wang L, Zhang H, Ruan Y, Chin DP, Xia Y, Cheng S, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–64.
World Health Organization. Global Tuberculosis Report 2017. 2017. http://www.who.int/tb/publications/global_report/en/. Accessed 13 Mar 2018.
He GX, van den Hof S, van der Werf MJ, Wang GJ, Ma SW, Zhao DY, et al. Infection control and the burden of tuberculosis infection and disease in health care workers in China: a cross-sectional study. BMC Infect Dis. 2010;10:313.
He GX, Wang LX, Chai SJ, Klena JD, Cheng SM, Ren YL, et al. Risk factors associated with tuberculosis infection among health care workers in Inner Mongolia, China. Int J Tuberc Lung Dis. 2012;16(11):1485–91.
Wei Z, Yang M, Quan B, Wang Y, Wu Y, Ji B. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays. J Hosp Infect. 2013;84(4):323–5.
Zhang X, Jia H, Liu F, Pan L, Xing A, Gu S, et al. Prevalence and Risk Factors for Latent Tuberculosis Infection among Health Care Workers in China: A Cross-Sectional Study. PLoS One. 2013;8(6):e66412.
Zhou F, Zhang L, Gao L, Hao Y, Zhao X, Liu J, et al. Latent tuberculosis infection and occupational protection among health care workers in two types of public hospitals in China. PLoS One. 2014;9(8):e104673.
He G, Li Y, Zhao F, Wang L, Cheng S, Guo H, et al. The prevalence and incidence of latent tuberculosis infection and its associated factors among village doctors in China. PLoS One. 2015;10(5):e0124097.
Chai SJ, Mattingly DC, Varma JK. Protecting health care workers from tuberculosis in China: a review of policy and practice in China and the United States. Health Policy Plan. 2013;28(1):100–9.
Ministry of Health People's Republic of China. Guidelines for implementing the National Tuberculosis Control Program in China. Beijing: Peking Union Medical College Publishing House; 2008 (in Chinese).
Ministry of Health People's Republic of China. Diagnostic criteria for pulmonary tuberculosis (WS 288–2008). Beijing: People's Medical Publishing House Press; 2008 (in Chinese).
Chin J. The prevalence of pulmonary tuberculosis in a national survey across China in 2010. Tubere Respir Dis. 2012;35(09):665–8 (in Chinese).
World Health Organization. Global tuberculosis control: WHO report 2011. http://apps.who.int/iris/bitstream/10665/44728/1/9789241564380_eng.pdf?ua=1. Accessed 13 Mar 2018.
World Health Organization. WHO policy on TB infection control in health-care facilities, Congregate settings and households. 2009. http://www.who.int/tb/publications/tb-facilities-policy/en/. Accessed 13 Mar 2018.
Long Q, Li Y, Wang Y, Yue Y, Tang C, Tang S, et al. Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study. BMC Health Serv Res. 2008;8:202.
Li Y, Ehiri J, Tang SL, Li DK, Bian YQ, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156.
Steingart KR, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti-Infect Ther. 2007;5(3):327–31.
Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev. 2011;24(2):314–50.
Ho J, Marks GB, Fox GJ. The impact of sputum quality on tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis. 2015;19(5):537–44.
Jaeger S, Karargyris A, Candemir S, Siegelman J, Folio L, Antani S, et al. Automatic screening for tuberculosis in chest radiographs: a survey. Quant Imaging Med Surg. 2013;3(2):89–99.
Davies PD, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis. 2008;12(11):1226–34.
Piccazzo R, Paparo F, Garlaschi G. Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (TB) and its role in the detection of latent TB infection: a systematic review. J Rheumatol Suppl. 2014;91:32–40.
Herath S, Lewis C. Pulmonary involvement in patients presenting with extra-pulmonary tuberculosis: thinking beyond a normal chest x-ray. J Prim Health Care. 2014;6(1):64–8.
China Food and Drug Administration (FDA). Mycobacterium tuberculosis rpoB gene and mutation detection kit (real-time PCR method) (trade name: Xpert (R) MTB / RIF) 2014.02.26. http://app2.sfda.gov.cn/datasearchp/index1.do?tableId=27&tableName=TABLE27&tableView=进口器械&Id=28263. Accessed 13 Mar 2018 (in Chinese).
Creswell J, Rai B, Wali R, Sudrungrot S, Adhikari LM, Pant R, et al. Introducing new tuberculosis diagnostics: the impact of Xpert((R)) MTB/RIF testing on case notifications in Nepal. Int J Tuberc Lung Dis. 2015;19(5):545–51.
Theron G, Pooran A, Peter J, van Zyl-Smit R, Kumar Mishra H, Meldau R, et al. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Eur Respir J. 2012;40(1):161–8.
Hu P, Bai L, Liu F, Ou X, Zhang Z, Yi S, et al. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China. Chin Med J. 2014;127(21):3744–50.
Dowdy DW, Davis JL, den Boon S, Walter ND, Katamba A, Cattamanchi A. Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa. PLoS One. 2013;8(8):e70485.
Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012;366(23):2161–2170.
We thank X. Nie, Q. Zhang, and N. Ta for their help in project management. We thank the staff at the participating facilities in Inner Mongolia for project organization and coordination, and administering the surveys and x-rays. We also thank the national radiologists in Beijing for their expert review of the x-ray films.
This publication was supported by the Cooperative Agreement Number 5U2GGH000018 from the U.S. Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of US CDC.
Availability of data and materials
All data generated from this analysis are published in the article. The dataset is not publically available because it contains sensitive information. Summary data may be available from the corresponding author upon reasonable request.
Ethics approval and consent to participate
HCWs provided written informed consent to participate in TB screening. The Chinese Ethical Committee for Tuberculosis Operational Research and the China Center for Disease Control and Prevention approved this project.
Consent for publication
None of the authors have a commercial or other financial interest associated with the information presented.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Cheng, S., Tollefson, D., He, G. et al. Evaluating a framework for tuberculosis screening among healthcare workers in clinical settings, Inner Mongolia, China. J Occup Med Toxicol 13, 11 (2018). https://doi.org/10.1186/s12995-018-0192-y
- Case detection
- Medical surveillance
- Clinically diagnosed cases
- Active case finding
- Healthcare workers
- Tuberculin skin test